Influence of degraded phosphatidylserine on binding of antiphospholipid antibodies

International Archives of Allergy and Immunology

Volumn 112, Issue 1, 1997, Pages 19-26

  Božič, Borut ^a   Kveder, Tanja ^a   Stegnar, Mojca ^b   Morosini Berus, Evridika ^c   Kos Golja, Mojca ^a   Peternel, Polona ^b   Rozman, Blaž ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Trnovo Hospital of Internal Medicine   (Slovenia)

^c Research and Development Division   (Slovenia)

Author keywords

Affinity purified antiphospholipid antibodies; Antiphospholipid syndrome; Phosphatidylserine age degraded; Specificity

Indexed keywords

PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN;

ADULT; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; PRIORITY JOURNAL;

EID: 0031060608     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237426     Document Type: Article

References (44)

1. Harris EN, Gharavi AE, Hughes GRV: Antiphospholipid antibodies, Clin Rheum Dis 1985; 11:591-609.
2. Triplett DA, Brandt JT, Musgrave KA, Orr C: Relationship between lupus anticoagulants and antibodies to phospholipids, JAMA 1988:259: 550-554.
3. McNeil PH, Chesterman CN, Krilis SA: Anti-cardiolipin antibodies and lupus anticoagulants comprise separate antibody infgroups with different phospholipid binding characteristics, Br J Haematol 1989;73:506-513.
4. Love PE, Santoro SA: Antiphospholipid antibodies; anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLF,) and in tton-SLE disorders, Prevalence and clinical significance, Ann Intern Med 1990:112: 682-698.
5. Stegnar M, Salobir-Pajnic B, Bozic B, Rozman B: Relationship between lupus anticoagulants and antiphospholipid antibodies detected by enzyme-linked immunosorbent assay, Acta Pharm 1992:42:109-115.
6. Cabiedcs J, Cabral AR, Alarcon-Segovia D: Identifications of IgG anticardiolipin antibodies in patients with primary antiphospholipid syndrome on the basis of their requirement for ß;-glycoprotein-l and their unmasking by heat, Clin Exp Rheumatol 1994:12:123-127.
7. Harris EN, Bagulcy E, Asherson RA, Hughes GRV: Clinical and serological features of the ‘anti-phospholipid syndrome' (APS), Ann Rheum Dis 1986:45:1-9.
8. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies, Proc Natl Acad Sci USA 1991:88:3069-3073.
9. Branch DW, Dudley DJ, Mitchell MD: Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss, Am J Obstet Gynecol 1990; 163:120-126.
10. Silver RM, Pierangeli SS, Gharavi AE, Harris EN, Eswin SS, Salafia CW, Branch DW: Induction of high levels of anticardiolipin antibodies in mice by immunisation with beta(2)-glycoprotein 1 does not cause fetal death, Am J Obstet Gynecol 1995;173:1410-1415.
11. Brey R, Branch DW, Harris EN, Triplett D: Meeting summary, Clin Exp Rheumatol 1992: 10:635-636.
12. Lockshin MD, Letendre CH: Antiphospholipid Antibody/Lupus Anticoagulant Workshop, Arthritis Rheum 1992; 10:1234-1237.
13. Harris EN, Pierangeli S: Anticardiolipin antibodies: Specificity and function, Lupus 1994:3: 217-222.
14. Alarcon-Segovia D, Cabral A: Antiphospholipid antibodies, Where do they come from? Where do they go? J Rheumatol 1994:21:982-989.
15. Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other ‘antiphospholipid’ antibodies, Blood 1994:84:2854-2867.
16. Maneta-Peyret L, Bessoule JJ, Geffard M, Cas-sagne C: Demonstration of high specificity antibodies against phosphatidylserine, J Immunol Methods 1988;108:123-127.
17. Staub HL, Harris EN, Khamashta MA, Savidge G, Chahade WH, Hughes GRV: Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis, Ann Rheum Dis 1989:48:166-169.
18. Qamar T, Gharavi AE, Levy RA, Lockshin MD: Lysophosphatidyl-ethanolamine is the antigen to which apparent antibody to phosphatidyl-cthanolamine binds, J Clin Immunol 1990:10: 200-203.
19. Stegnar M, Bozic B, Petcmcl P, Kveder T, Vcne N, Rozman B: Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis, Thromb Res 1991;63:433-443.
20. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsu-kamoto M: Detection of bcta-2-glycoprotcin-l-dependent antiphospholipid antibodies and an-ti-beta-2-glycoprotcin-l antibody in patients with systemic lupus erythematosus and in patients with syphilis, Int Arch Allergy Immunol 1994:103:239-244.
21. Lin L, Shroyer L, Walther A, Lyden TW, Kau Ng A, Rote NS: Monoclonal IgM antiphospha-tidylserine antibody reacts against cytoskele-ton-like structures in cultured human umbilical cord endotehlial cells, Am J Reprod Immunol 1995:33:97-107.
22. Rauch J, Janoff AS: Phospholipid in the hexagonal II phase is immunogenic: Evidence for immunorecognition of nonbilayer lipid phases in vivo, Proc Natl Acad Sci USA 1990:87: 4112-4114.
23. Bevers EM, Galli M, Barbui Comfurius P, Zwaal RFA: Lupus anticoagulant IgG’s (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin Thromb Haemost 1991;66:629-632.
24. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T: Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor, J Immunol 1992:148:3885-3891.
25. Hunt J, Krilis S: The fifth domain of glycoprotein I contains a phospholipid binding site (Cys28l Cys288) and a region recognized by anticardiolipin antibodies, J Immunol 1994: 152:653-659.
26. Shibata S, Harpcl PC, Gharavi Ah, Rand J, Fillit H: Autoantibodies to heparin from patients with APS inhibit formation of antithrombin III-thrombin complexes, Blood 1994:83:2532-2540.
27. Harris EN: Serological detection of antiphospholipid antibodies, Stroke 1993;23/2(suppl 1): 3-6.
28. Toschi V, Motta A, Castelli C, Gibclli S, Cimmi-niello C, MolaroGL, Gibelli A: Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in SLE, I lac-mostasis 1993:23:275-283.
29. Santoro SA: Antiphospholipid antibodies and thrombotic predisposition: Underlying pathogenetic mechanisms, Blood 1994:83:2389-2391.
30. Ashcrson RA, Cervera R: ‘Primary’, ‘secondary’ and other variants of the antiphospholipid syndrome, Lupus 1994:3:293-298.
31. Tan EM, Cohen AS, Fries JF, Masi AT, McShanc DJ, Rothlicld NF, Green Schaller J, Talal N, Winchester RJ: The 1982 revised criteria for classification of SLE, Arthritis Rheum 1982: 25:1271-1277.
32. Heape AM, Juquelin IL Boiron F, Cassagne C: Improved one-dimensional thin-layer chromatographic technique for polar lipids, J Chromatogr 1985:322:391-395.
33. Touchstone JC, Levin SS, Dobbins MF, Carter PJ: Differentiation of saturated and unsaturated phospholipids on thin layer chromatograms, J High Rcsol Chromatogr Chromatogr Commun 1981;44:23-24.
34. Cabral AR, Cabiedes J, Alarcon-Segovia D: Hemolytic anemia related to an IgM autoantibody to phsophatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes, J Autoimmun 1990:3:773-787.
35. Harris EN, Gharavi AE, Loizou S, Dcrue G, Chan JK, Patel BM, Mackworth-Young CG, Bunn CC, Hughes GRV: Cross-reactivity of antiphospholipid antibodies, J Clin Lab Immunol 1985;16:1-9.
36. Pengo V Thiagarajan P, Shapiro SS, Ileine MJ: Immunological speciftcty and mechansim of action of lgG LAC, Blood 1987:70:69-76.
37. Exner T, Sahman N, Tnidingcr B: Separation of anticardiolipin antibodies from lupus anticoagulant on phospholipid-coated polystyrene column, Biochent Biophys Res Commun 1988; 155:1001-1007.
38. McNeil HP, Chesterman CN, Krilis SA: Binding specificity of lupus anticoagulants and car-diolipin antibodies, Thromb Res 1988:52:609-619.
39. Chamlcy LW, Pattison NS, McKay EJ: Separation of lupus anticoagulant from anticardiolipin antibodies by ion-exchange and gel filtration chromatography, Haemostasis 1991;21:25-29.
40. Levy RA, Gharavi AE, Sammaritano LR, Habi-na L, Lockshin MD: Fatty acid chain is a critical epitope for antiphospholipid antibodies, J Clin Immunol 1990:10:141-145.
41. Berger A, German JB, Gerschwin ME: Implication of modifying cardiolipin acyl composition by diet, I, Cardiolipin acyl chain is an important determinant in the binding to antiphospholipid antibodies in SLE sera, J Autoimmun 1992:5: 229-241.
42. Connor J, Pak CC, Schroit AJ: Exposure of phosphatidylscrinc in the outer leaflet of human red blood cells, J Biol Chcm 1994:269:2399-2404.
43. Bevers EM, Smeets EF, Comfurius P, Zwaal RFA: Physiology of membrane lipid asymmetry, Lupus 1994:3:235-236.
44. Wu JR, Lentz BR: Phospholipid specific conformation changes in human prothrombin upon binding to procoagulant acidic lipid membranes, Thromb Haemost 1994:71:596-604.